12479455 · Active · incorporated 6 years, 6 months ago · London
Biotech Biotech & Life Sciences Deep Tech Drug Discovery Healthcare Series A
Develops natural killer (NK) cell and small molecule therapies for cancer treatment, harnessing the innate immune system.
Nk:io Ltd is a private limited company registered at Companies House under number 12479455, incorporated on 24 February 2020, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 49 filings for this company, including 3 funding rounds. Its most recent round closed in December 2024, raising £100k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 3 | Dec 2024 | £100k | £1.73 |
| Round 2 | Feb 2023 | £2m | £1.73 |
| Round 1 | Mar 2022 | £2.2m | £1.73 |
Showing the 10 most recent of 49 filings.
See the complete cap table with every shareholder, founder tags, dilution across 16 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.